美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Principia Biopharma Inc.

100.05

0.0000

成交量：- -

成交额：- -

市值：33.28亿

市盈率：-44.01

高：100.05

开：100.05

低：100.05

收：100.05

52周最高：101.89

52周最低：25.35

股本：3,325.99万

流通股本：2,304.04万

量比：- -

换手率：- -

股息：- -

股息率：- -

每股收益(TTM):-2.2732

每股收益(LYR):-2.0867

净资产收益率：-26.40%

总资产收益率：-16.03%

市净率：9.47

市盈率(LYR):-47.95

数据加载中...

总览公司新闻资讯公告

公司资料

公司名字：

Principia Biopharma Inc.

交易所：

NASDAQ

成立时间：

- -

员工人数：

- -

公司地址：

- -

官网：

http://www.principiabio.com

邮编：

- -

电话：

- -

传真：

- -

简介：

Principia Biopharma Inc.于2008年10月6日在特拉华州注册成立，于2011年2月开始运营，总部位于加利福尼亚州南旧金山。该公司是一家临床阶段的生物制药公司，致力于开发免疫学和肿瘤学的新疗法。他们专有的Tailored Covalency平台使他们能够设计和开发可逆的共价和不可逆的共价小分子抑制剂，其效力和选择性可以与可注射的生物制剂相媲美，同时保持药丸的便利性。Principia Biopharma已经从他们的平台生产了三种新的候选药物，在其运作的前七年中产生了四种临床计划。

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/PRNB/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PRNB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PRNB\",,,,,undefined,":{"symbol":"PRNB","market":"US","secType":"STK","nameCN":"Principia Biopharma Inc.","latestPrice":100.05,"timestamp":1601064000000,"preClose":100.05,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":23040425,"shares":33259922,"eps":-2.27321,"marketStatus":"停牌","change":0,"latestTime":"09-25 16:00:00 EDT","open":100.05,"high":100.05,"low":100.05,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.27321,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1779264000000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1536897600000,"exchange":"NASDAQ","adjPreClose":100.05,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PRNB\",,,,,undefined,":{"symbol":"PRNB","floatShares":23040425,"roa":"-16.03%","roe":"-26.40%","lyrEps":-2.08673,"shares":33259922,"dividePrice":0,"high":100.05,"amplitude":0,"preClose":100.05,"low":100.05,"week52Low":25.35,"pbRate":"9.47","week52High":101.89,"institutionHeld":0,"latestPrice":100.05,"eps":-2.27321,"divideRate":0,"volume":0,"delay":0,"ttmEps":-2.27321,"open":100.05,"prevYearClose":54.78},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PRNB\",params:#limit:5,,,undefined,":[{"market":"US","date":"2020-09-29","symbol":"PRNB","reason":null,"defaultRemindTime":1601386200000,"announcedDate":"2020-09-22","type":"delisting","dateTimestamp":1601352000000},{"market":"US","date":"2020-08-06","symbol":"PRNB","fiscalQuarterEnding":"2020/06","expectedEps":-0.7,"name":null,"time":"盘后","type":"earning","dateTimestamp":1596686400000,"reportTimeType":"post","actualEps":0.31},{"market":"US","date":"2020-05-06","symbol":"PRNB","fiscalQuarterEnding":"2020/03","expectedEps":-0.79,"name":null,"time":"","type":"earning","dateTimestamp":1588737600000,"reportTimeType":"","actualEps":-0.99},{"market":"US","date":"2020-03-10","symbol":"PRNB","fiscalQuarterEnding":"2019/12","expectedEps":-0.78,"name":null,"time":"盘后","type":"earning","dateTimestamp":1583812800000,"reportTimeType":"post","actualEps":-0.8},{"market":"US","date":"2019-11-05","symbol":"PRNB","fiscalQuarterEnding":"2019/09","expectedEps":-0.85,"name":null,"time":"","type":"earning","dateTimestamp":1572930000000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PRNB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PRNB\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PRNB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PRNB","date":"2020-09-25","current":-44.012652,"percent":0.462338,"low":-124.629826,"twenty":-107.219667,"median":-47.266471,"eighty":-29.279962,"high":123.127587,"avg":-27.017627,"sd":57.598869,"marketCap":3324329203},"quantilePoints":[],"updateTime":1779252041679},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.principiabio.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.006},{"period":"1month","weight":0.0332},{"period":"3month","weight":0.0691},{"period":"6month","weight":0.1244},{"period":"1year","weight":0.2335},{"period":"ytd","weight":0.076}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Principia Biopharma Inc.于2008年10月6日在特拉华州注册成立，于2011年2月开始运营，总部位于加利福尼亚州南旧金山。该公司是一家临床阶段的生物制药公司，致力于开发免疫学和肿瘤学的新疗法。他们专有的Tailored Covalency平台使他们能够设计和开发可逆的共价和不可逆的共价小分子抑制剂，其效力和选择性可以与可注射的生物制剂相媲美，同时保持药丸的便利性。Principia Biopharma已经从他们的平台生产了三种新的候选药物，在其运作的前七年中产生了四种临床计划。","exchange":"NASDAQ","name":"Principia Biopharma Inc.","nameEN":"Principia Biopharma Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"PRNB\",market:\"US\",,,undefined,":null}}